Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Description AOD-9604 is a modified fragment of human growth hormone (hGH amino acids 177-191) with an N-terminal tyrosine, developed by Professor Frank Ng at Monash University in collaboration with Metabolic Pharmaceuticals Ltd (Australia)
Like the Wegovy pen, the pill contains semaglutide and is FDA-approved for chronic weight management
Typical dosages range from 1000 mcg, varying by administration frequency
Nonetheless, this work has identified novel findings that support future studies to determine whether microbiome changes are contingent upon the combination of both NNMTi and LD switch and mediated through direct NNMTi-driven mechanisms or through indirect mechanisms such as weight or fat loss 8,13
Meet the Wegovy Pill Lose 14-15% of your body weight* A new, FDA-approved way to take Wegovy, no injections required
(PubMed) Laird E, O'Halloran AM, Molloy AM, et al
